Home › Funds › Fidelity Management & Research (FMR) › PRME
Fidelity Management & Research (FMR) position in PRME
PRIME MEDICINE INC · Health Care
Latest position (Q2 2026)1.76M sh
Reported value held$6.50M
Portfolio Weight0.00%
First reportedQ4 2022
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 8.46M | $157.24M | New |
| Q1 2023 | 8.52M | $104.76M | Add |
| Q2 2023 | 4.04M | $59.17M | Reduce |
| Q3 2023 | 3.92M | $37.42M | Reduce |
| Q4 2023 | 3.93M | $34.78M | Hold |
| Q1 2024 | 3.92M | $27.47M | Hold |
| Q2 2024 | 3.93M | $20.19M | Hold |
| Q3 2024 | 3.74M | $14.49M | Reduce |
| Q4 2024 | 3.80M | $11.10M | Add |
| Q1 2025 | 3.75M | $7.46M | Reduce |
| Q2 2025 | 3.74M | $9.25M | Hold |
| Q3 2025 | 2.81M | $15.58M | Reduce |
| Q4 2025 | 2.18M | $7.55M | Reduce |
| Q1 2026 | 1.77M | $6.16M | Reduce |
| Q2 2026 | 1.76M | $6.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRME
- BlackRock Inc 9.60M sh · $35.43M · Q2 2026
- ARK Invest 8.35M sh · $30.81M · Q2 2026
- Vanguard Group 6.47M sh · $22.44M · Q4 2025
- Balyasny Asset Management 3.97M sh · $14.65M · Q2 2026
- Goldman Sachs Group 3.43M sh · $12.66M · Q2 2026
- Casdin Capital 3.17M sh · $11.69M · Q2 2026
- UBS Group AG 2.79M sh · $10.31M · Q2 2026
- Geode Capital Management 2.71M sh · $10.01M · Q2 2026
- Citadel Advisors 2.35M sh · $8.68M · Q2 2026
- Two Sigma Investments 1.52M sh · $5.63M · Q2 2026
- Farallon Capital Management 1.24M sh · $4.58M · Q2 2026